Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03145428 · ClinicalTrials.gov registry record
Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT03145428 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 3,000 participants.
The verdict
NCT03145428 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinical performance of MDW for detection of sepsis in the ED.
Interventions
- DIAGNOSTIC_TEST CBC-Diff Monocyte volume width distribution (MDW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2018-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03145428
The ClinicalTrials.gov registry entry for NCT03145428 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CBC-Diff Monocyte volume width distribution (MDW) is the first listed.
NCT03145428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03145428 about?
NCT03145428 is a clinical study titled "Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis". The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinic...
What is the current status of trial NCT03145428?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2017-06-19. Estimated completion is 2018-01-26.
What interventions are being tested in trial NCT03145428?
The interventions under investigation include: CBC-Diff Monocyte volume width distribution (MDW) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03145428?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.